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Abstract
Background: Staphylococcus aureus is often responsible for fatal infections and recent upsurge of  resistant strains has 
resulted in therapeutic failure.  The identification of  this microorganism is a major challenge to medical microbiologists in 
developing countries. 
Methods: One hundred and eighty five isolates which had been previously isolated from the nares of  185 healthy college 
students’ volunteers in Amassoma, Bayelsa State, South Nigeria were identified by MALDI TOF mass spectrometry, and 
PCR amplification of  the spa gene. The identified isolates were compared with presumptive identities obtained by growth 
on MSA, tube coagulation and slide agglutination tests. Antimicrobial susceptibility testing of  S. aureus isolates was per-
formed by Kirby Bauer technique while MRSA was screened for by growth on chromIDTM MRSA plate and confirmed by 
PCR-amplification of  mecA/mecC genes. 
Results: From the 185 staphylococci that grew with yellow colonies on MSA, 24 were positive in the slide coagulase test, 
while 17 were positive in the tube coagulase test; MALDI TOF mass spectrometry and PCR amplification of  the spa gene 
showed excellent concordance with the tube test, as all tube coagulase-positive strains were identified as S. aureus, while 
tube coagulase-test negative isolates in all cases were designated as other staphylococcal species by MALDI-TOF mass 
spectrometry and were spa PCR test negative. All S. aureus isolates were susceptible to clindamycin, vancomycin, fusidic 
acid, rifampicin and linezolid, while observed resistance to penicillin and trimethoprim were high. Only one MRSA strain 
was detected
Conclusion: The study confirms that the tube coagulase test is an accurate diagnostic method for identification of  S. aureus, 
while growths on MSA and slide agglutination tests are inaccurate. We found a low prevalence of  MRSA and a high rate of  
trimethroprim-resistance in the studied population.
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Staphylococcus aureus is an important pathogen caus-
ing a wide range of  infections e.g abscesses, furuncles, 
osteomyelitis, infective endocarditis and bacteremia. It 
is a major cause of  severe nosocomial and communi-
ty-acquired infections1.  Its carriage in the anterior nar-
es, considered to be the ecologic niche, plays a key role 
in the epidemiology of  this pathogen2.
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S. aureus can acquire resistance to many anti-micro-
bial agents. Of  particular concern is the synthesis of  
penicillin-binding protein (PBP) 2A that confers resist-
ance to all β-lactam antimicrobial agents. Such strains 
are designated methicillin-resistant S. aureus (MRSA). 
PBP 2A is encoded by the mecA gene cassette, that 
can be detected by PCR and other DNA-based meth-
ods. Recently, a novel mecA homologue mecCLGA251 
has been described3. The novel mecA gene also con-
fers resistance to β-lactam antibiotics but escapes de-
tection by molecular diagnostic tests currently used 
for identification of  MRSA3. Genetic techniques have 
been used to study the evolution of  the MRSA clones 
that have emerged since the early 1960s, and to study 
their worldwide dissemination. The early MRSA clones 
were hospital-associated (HA-MRSA). However, there 
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is now an evolution of  community-associated MRSA 
(CA-MRSA) clones. CA-MRSA mostly causes skin or 
soft-tissue infections as well as deep-seated infections 
such as necrotizing pneumonia.  
The culture characteristics of  S. aureus on various se-
lective media have served as the basis for its presump-
tive identification4. In an attempt to achieve presump-
tive isolation of  pathogenic staphylococci from clinical 
samples in a single step, Mannitol Salt Agar (MSA) was 
developed in 19455,6. Several modifications of  MSA 
were subsequently described7,8. The key to the pre-
sumptive identification of  S. aureus on MSA is the se-
lective growth in the presence of  5 - 6.5% NaCl and 
yellow pigmented colonies resulting from fermentation 
of  mannitol9.
The molecular identification of  S. aureus strains can be 
established by detecting the presence of  staphylococci 
protein A, (spa). The spa typing method is based on 
sequencing of  the polymorphic X region of  the protein 
A gene present in all strains of  Staphylococcus aureus10 
Also, a rapid and accurate method for identification of  
microorganisms is the matrix-assisted laser desorption 
ionization–time of  flight (MALDI-TOF) mass spec-
trometry.11
In some developing countries, S. aureus is usually iden-
tified by growth and production of  yellow colonies on 
MSA and the presumptive identification may be con-
firmed by a rapid agglutination kit or tube coagulase 
test. However, it has been observed that some of  the re-
sults are often misleading because organisms that were 
identified as S. aureus with these methods may not be S. 
aureus but other staphylococci.  There is therefore the 
need to compare commonly used methods of  identifi-
cation in Nigeria with other identification methods  to 
determine the degree of  accuracy of  these commonly 
used methods. The aims of  this study therefore are to 
compare the diagnostic accuracy of  growth on MSA, 
tube coagulase, latex agglutination slide test with pres-
ence of  spa gene and MALDI TOF for identification 
of  S. aureus and to determine the resistance pattern 
of  isolated S. aureus strains to selected antibiotics with 
screening for MRSA in the isolated S. aureus strains and 




One hundred and eighty five non duplicated strains 
which were previously isolated from the nares of  185 
healthy college students volunteers aged between 16 and 
35 years of  Niger Delta University, Ammasoma, Bayel-
sa State, (a state in South-South Nigeria) between Janu-
ary and August, 2011 had been presumptively identified 
as S. aureus through growth and production of  yellow 
colonies on MSA. MSA is regarded as a presumptive 
media in the identification of  S. aureus and differen-
tiation of  coagulase-positive staphylococci from coag-
ulase-negative staphylococci. For the present study, all 
the strains were repeatedly streaked on MSA (Oxoid, 
UK) and incubated for 48 hours at 370C. All strains that 
grew on MSA with characteristic yellow colonies were 
used in further tests. 
Identification of  strains
Coagulase tests
The strains that produced bound coagulase (BC) were 
detected in all strains that grew on MSA with yellow col-
onies by a rapid agglutination kit for identification of  S. 
aureus: (Slidex® Staph PLUS. bioMérieux, France) ac-
cording to the manufacturer’s instructions. Slidex Staph 
Plus is based on a triple detection system: blue latex 
particles sensitized with human fibrogen and mono-
clonal antibodies simultaneously detect clumping fac-
tor, Protein A and group-specific antigen bound to the 
S. aureus-specific peripheral structure. All strains that 
grew on MSA with yellow colonies were also inoculat-
ed into a tube containing horse plasma (SSI, Denmark) 
and incubated at 370C for 4 hours. The tube coagulase 
test detects free cogulase produced by the staphylococci 
by coagulating plasma. 
Detection of  Spa gene.
The polymorphic X region of  the staphylococcal pro-
tein A gene present in almost all S. aureus described by 
Harmsen et al,10 was amplified for all isolated strains in 
a total volume of  50 μl by adding 1μl of  a 1:500 dilution 
of  genomic DNA, 1 µl of  25Mm MgCl2, 1 µl of  for-
ward primer, 1 μl of  reverse primer, 21 μl of  water and 
25 μl of  AmpliTaq Gold® 360 Mastermix into a 0.2-
ml PCR tube. Primers used were spa-1113F (5'-TAAA-
GACGATCCTTCGGTGAGC-3') and spa-1415R 
(5'-CAGCAGTAGTGCCGTTTGCTT-3'). A negative 
control (plain mastermix) and a positive control (from 
our laboratory's S. aureus collection) were included. 
Tubes were capped and placed in a Veriti Thermal Cy-
cler (Applied Biosystems). Thermal cycling conditions 
included an initial 10 min at 95°C followed by 32 cycles 
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of  30s at 94°C, 30 s at 55°C, and 60 s at 72°C; and a 
final extension at 72°C for 10 min. PCR products were 
resolved by agarose (1 %) gel electrophoresis previously 
stained with GelRed (Biotium Inc, Hayward, CA, USA) 
and run at approximately 40 mAmp for 45 min. The 
molecular marker used was a pUC mix Marker 8. The 
size of  the PCR products was 400-600 bp for the spa 
gene. This test is the first gold standard to compare the 
accuracy of  tube and slide coagulase test and growth 
on MSA. 
MALDI mass spectrometry. 
Identification of  all isolated strains was carried out by 
MALDI mass spectrometry. A thin smear of  18 h old 
culture was deposited on a MALDI plate. The samples 
were overlaid with 1 µl of  matrix solution (saturated 
solution of  cyano-4-hydroxycinnamic acid in 50% ace-
tonitrile and 2.5% trifluoroacetic acid). The matrix sam-
ple was crystallized by air drying at room temperature. 
Measurements were performed with a Microflex mass 
spectrometer (Bruker Daltonik, Bremen, Germany) 
using FlexControl software (version 3.0). Spectra were 
recorded in the positive linear mode (laser frequency, 
20 Hz; ion source 1voltage, 20 kV; ion source 2 volt-
age, 18.4 kV; lens voltage, 9.1 kV; mass range, 2,000 to 
20,000 Da). For each spectrum 240 shots in 40-shot 
steps from different positions of  the target spot were 
collected and analyzed.
Results of  the pattern-matching process were expressed 
as proposed by the manufacturer with scores ranging 
from 0 to 3. For each isolate, the highest score of  a 
match against a spectrum in the database was used for 
identification. Scores below 1.7 were considered not to 
have generated a reliable identification; a score of  1.7 
was considered identification to genus, and a score of  
2.0 was used for species identification. This test is the 
second gold standard to compare the accuracy of  tube 
and slide coagulase test and growth on MSA
 
Antibiotic susceptibility testing
Antibiotic susceptibility testing of  all S. aureus strains 
was performed by Kirby Bauer  technique according 
to the European Committee on Antimicrobial Suscep-
tibility Testing (EUCAST) guidelines (www.eucast.org) 
using standard antibiotic discs (Oxoid, UK  namely: fu-
sidic acid, linezolid, ampicillin, norfloxacin, rifampicin, 
penicillin, clindamycin, erythromycin, cefoxitin, tobra-
mycin, trimethoprim and vancomycin were placed firm-
ly on an agar plates by a disc dispenser. The plates were 
incubated at 370C for 24 hrs and examined for clear 
zones of  inhibition around the discs. The diameter of  
inhibition was measured and compared with standard 
zones to determine resistance
Detection of  MRSA
Growth on MRSA plates
All S. aureus strains that were resistant to cefoxitin were 
subcultured on a chromogenic medium, chromIDTM 
MRSA plate (bioMérieux, France). After incubation, 
strains that grew on the plates with green colouration 
were selected for further studies. 
SLIDEX MRSA detection
All S. aureus strains that were resistant to cefoxitin were 
tested for the presence of  Penicillin Binding Protein-2 
(PBP-2). This was performed with Slidex MRSA Detec-
tion Kit (bioMérieux, France) according to the manu-
facturer’s instructions. This is a slide agglutination assay 
that detects PBP2a in MRSA by use of  latex sensitised 
with a monoclonal antibody directed against PBP2a
Detection of  MecA and coagulase gene
PCR amplification of   mecA/(mecC(LGA251)) gene.
PCR assay was performed for all suspected MRSA 
strains to amplify a region of  mecA  including the 
novel homologue mecC (mecALGA251) according to 
García-Álvarez et al (3) . Primers were as follows: Fw, 5´ 
TCACCAGGTTCAACY]CAAAA 3´; and Rv, 5´ CCT-
GAATCW]GCTAATAATATTTC 3´.  
PCR reaction contained 50 μl reaction volume of  Am-
pliTaq Gold® 360 Mastermix (2x stock including PCR 
buffer, TAQ-polymerase, MgCl2 and dNTPs) with 0.5 
μl of  each primer (stock for 100 pmol/μl (LGA251) 
and 25 pmol/μl (Coa)) and 10 μl template for each. The 
mixture was prepared as freezer-mix (ready-to-use just 
as add 10 μl template to 40 μl mix freshly thawed).   
A negative control, with no target DNA, was includ-
ed in the PCR and run in the Veriti Thermal Cycler 
(Applied Biosystems) and a positive control the ampli-
fication programme consisted of  an initial denaturation 
step at 95°C for 10 min; 40 cycles of  denaturing at 95°C 
for 1 min, annealing at 55°C for 1 min and extension at 
72°C for 2 min; and a final extension at 72°C for 5 min. 
PCR products were resolved by agarose (1 %) gel elec-
trophoresis previously stained with GelRed (Biotium 
Inc, Hayward, CA, USA) and run at approximately 40 
mAmp for 45 min. The molecular marker used was a 
pUC mix Marker 8. The size of  the PCR products were 
356 bp for the mecA/mecC gene.
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Determination of  Minimum Inhibitory Concentra-
tion (MIC)
The MIC of  antibiotics were determined in the MRSA 
and selected methicillin susceptible S. aureus (MSSA) 
for comparison using Gram-positive (GP) AST P-580 
antibiotics sensitivity cards (bioMérieux, France) by 
Vitek-2 apparatus (bioMérieux) according to the manu-
facturer’s instructions. The system determined the sus-




The nasal carriage rate of  S. aureus strains in the studied 
bacterial population is 9%. All 185 strains grew as yel-
low colonies on MSA and all the strains were identified 
by MALDI TOF as staphylococci. 168 were coagulase 
negative staphylococci (CNS) while 17 strains from the 
total strains were identified as S. aureus. 
The presence or absence of  spa gene in the 185 strains 
were detected by PCR amplification of  the gene. There 
was amplification only in 17 strains and the strains were 
identified as S. aureus by MALDI TOF (Table I). All the 
185 strains were tested for ability to coagulate plasma 
using agglutination kit and tube coagulase test. All the 
strains identified by MALDI TOF as S. aureus were also 
tube-coagulase positive (Table I). Twenty four isolates 
were positive in agglutination kit test. Isolates positive 
in agglutination kit but negative in tube coagulase test 
were identified as S. xylosus. . Three strains had positive 
result in tube coagulase test, spa-PCR and identified as 
S. aureus by MALDI TOF but had negative result in 
slide agglutination test. 
Table 1: Comparison of Accuracies of Identification Methods for  
Isolated S. aureus Strains 
 
Gold Standards Other Tests   
MALDI and spa Tube Coagulase Slide agglutination MSA 
17 S. aureus 17 S. aureus 14 S. aureus 185 P. S. aureus 
168 CNS 168 CNS 171CNS - 
 Sensitivity 1 0.82 0.1 
 Specificity 1 0.95 - 
 
Note=P is presumptive identified S.aureus which is only correct for 17 out of 185 isolates 
The studied S. aureus strains were generally susceptible 
to the tested antibiotics except penicillin and trimethop-
rim. All the tested strains were resistant to penicillin ex-
cept 3 strains. 53% of  the isolates were also completely 
resistant to trimethoprim with no zone of  inhibition. 
All the tested isolates were susceptible to clindamycin, 
vancomycin, fusidic acid, rifampicin and linezolid. 7% 
of  the tested strains were resistant to erythromycin and 
cefoxitin while 24% of  the tested strains were resistant 
to norfloxacin. (Table II). 
Table II: Percentage Resistance of Isolated S. aureus strains to antibiotics 
  




Ampicillin 3 18 
Norfloxacin 4 24 
Penicillin 13 77 
Erythromycin 1 6 
Cefoxitin 1 6 
Tobramycin 2 12 
Trimethoprim 9 53 
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Only one MRSA strain was detected in the studied 
population and the MRSA carriage in the studied pop-
ulation is 0.5%.  The MRSA strain (S. aureus FA91) 
grew on chromIDTM MRSA plate, produced PBP-2 
by Slidex MRSA Detection Kit and was confirmed as 
MRSA by detection of   mecA/C by PCR.  Compari-
son of  the susceptibility pattern of  the isolated MRSA 
with 3 MSSA revealed that the isolated MRSA was rel-
atively susceptible to tested antibiotics with resistance 
observed only to beta lactams and trimethoprim. (Table 
III).
Table III: Comparison of Resistance Pattern of Isolated MRSA and  
Selected MSSA by Determination of MIC. 
 
 Minimum Inhibitory Concentration of MRSA and MSSA 
Antibiotics MRSA FA91 MSSA FA28 MSSA FA213 MSSA FA293 
Cefoxitin screen + - - - 
Penicillin R  ˃ 0.5 R ˃ 0.5 S R ˃ 0.5 
Oxacillin R 1 S S S 
TMP/SMX R 160 R ˃ 320 S R ˃ 320 
Gentamycin S R 16 S S 
Tobramycin S R 16 S S 
Levofloxacin S R 8 S S 
Moxifloxacin S R 2 S S 
Tetracycline S R 16 S S 
 
Note- MRSA: Methicillin Resistant Staphylococcus aureus 
MSSA: Methicillin Susceptible Staphylococcus aureus 
                                                                       R- Resistant 
S:-Susceptible 
Discussion
Microbiologists in developing countries rely on bio-
chemical tests and growth on selective media to identify 
pathogens. Often, these identifications are inaccurate 
resulting in inappropriate prescription and use of  anti-
biotics for misidentified pathogens12. From the studied 
185 organisms that grew with yellow colonies on MSA 
in this study, 168 are CNS while 17 were identified as 
S. aureus by MALDI TOF.   Furthermore, the accuracy 
of  identification of  S. aureus strains by coagulase tests 
was tested with amplification of  spa gene and MALDI 
TOF. The spa gene is specific to S. aureus and expres-
sion of  this gene provides useful strain identification 
10,13. Identification using whole cell protein profiles by 
MALDI-TOF–MS has been found useful and accurate 
in identifying most bacterial strains including S. aureus 
strains11.
The tube coagulase test (horse plasma) is 100% accu-
rate in identifying  S. aureus strains, however slide ag-
glutination method is not only positive for S. aureus but 
also for S. xylosus strains and three S. aureus strains 
were negative in slide agglutination test. Therefore, the 
slide agglutination test and growth on MSA is inaccu-
rate for sole identification of  S. aureus while the tube 
coagulase test is totally accurate for identification of  S. 
aureus strains. 
The S. aureus strains isolated from this study were gener-
ally susceptible to the tested antibiotics except trimeth-
oprim. This observed susceptibility may be because the 
strains were isolated from healthy carriers in the com-
munity. The high rate of  resistance to trimethroprim by 
S. aureus strains found in this study is very disturbing. 
The combination of  trimethoprim and sulfamethozole 
(co-trimoxazole) is widely used for various infections 
in Nigeria because of  its low cost compared with oth-
er antibiotics. It is also commonly used as prophylaxis 
for HIV infected patients who have a high occurrence 
in Nigeria. This may account for a possible higher se-
lective pressure on the agent therefore, accounting for 
increased rate of  resistance.  Huovinen et al.14 observed 
a clear trend in the resistance to TMP-SMX with strains 
isolated in the developing world being more often re-
sistant than the strains isolated in the developed coun-
tries. The clinical significance of  this finding is that 
resistance to co-trimoxazole has been associated with 
concurrent resistance to other antibiotics resulting in 
multi-drug resistant pathogens.15.
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There are conflicting reports about the prevalence of  
MRSA strains in Nigeria. Ghebremedhin et al.1 report-
ed a prevalence rate of  20.23% of  MRSA and 47% of  
CA-MRSA in Nigeria, Taiwo et al.16 reported a preva-
lence rate of  29% while 1.4% prevalence rate was re-
ported by Adesida et al.17.  Only one MRSA was detect-
ed in this study. This shows a low prevalence rate of  
MRSA in the studied population.
The MRSA isolated in this study is resistant to trimeth-
oprim and beta lactams while generally susceptible to 
other tested antibiotics. Interestingly, an MSSA strain 
was highly resistant to tested antibiotics while the stud-
ied MRSA was very susceptible to tested antibiotics. The 
MRSA has the susceptibility pattern of  CA-MRSA ac-
cording to Fridkin et al.18 who reported that CA-MRSA 
are generally susceptible to most antimicrobial agents 
with the exception of  beta-lactams and erythromycins. 
Lack of  multidrug resistance in an MRSA may be an 
indication that it is CA-MRSA. 
This investigation confirms that coagulation of  horse 
plasma in tube coagulase test is reliable and accurate 
identification method for identifying S. aureus strains 
and that slide agglutination test is not totally accurate. It 
also confirms that growth with mannitol fermentation 
(yellow) colonies on MSA cannot differentiate between 
S. aureus and CNS colonies on MSA. This observa-
tion was confirmed by Adebayo et al.,9 who observed 
growth of  CNS on MSA.  It also showed low prev-
alence of  MRSA in the studied population. The high 
rate of  resistance to trimethroprim by S. aureus strains 
found in this study calls for control in the use of  the 
antibiotics in Nigeria
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